NSD1 and hepatocellular carcinoma: Collectively, our data from this study shows that CRISPR/Cas9-mediated gene knockout of NSD1 can inhibit HCC cell proliferation, migration and invasion both in vitro and in vivo through H3K27me3 enrichment and Wnt10b downregulation.